DIOSynVax

DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform.

The company's technology applies protein structure modelling and immune optimisation to engineer synthetic vaccine antigen payloads targeting conserved regions of viruses, enabling protection across multiple strains and variants.

Its pipeline includes vaccine candidates against betacoronaviruses, influenza including avian H5Nx strains, and haemorrhagic fever viruses. The betacoronavirus candidate has completed Phase I/II human safety trials.